Multicenter Study on Transarterial Chemoembolization Combined with Radiofrequency Ablation for Early-Stage Hepatocellular Carcinoma: Primary versus Recurrent HCC
TACE plus RFA has similar clinical efficacy and safety for both primary and recurrent early HCC. Compared with patients with primary HCC, those with recurrent disease had significantly shorter PFS times.
Authors
- Yutang Chen (ORCID: https://orcid.org/0000-0002-4748-8811)
- Xia You
- Shaojie Wu
- Yi Tang (ORCID: https://orcid.org/0000-0002-2250-6024)
- Junming Xu (ORCID: https://orcid.org/0000-0002-5919-7966)
- Zhu-ting Fang (ORCID: https://orcid.org/0000-0003-3350-2210)
- Bing Chen (ORCID: https://orcid.org/0009-0006-2692-0595)
Institutions
- Fujian Medical University (CN)
- Fudan University Shanghai Cancer Center (CN)
- Zhangzhou Municipal Hospital of Fujian Province (CN)
- Fujian Provincial Hospital (CN)
- Fuzhou University (CN)
Publication Details
- Journal
- Journal of Hepatocellular Carcinoma
- Published
- 2024-12-01
- DOI
- https://doi.org/10.2147/jhc.s497956
- Citations
- 5
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 1.85
Funders
- Fujian Medical University